Trials / Withdrawn
WithdrawnNCT00935142
Non-invasive Imaging With [18F]VM4-037
Non Invasive Imaging of [18F]VM4-037 With Positron-Emission-Tomography (PET): A Phase I Trial
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Maastricht Radiation Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the toxicity of the hypoxia PET-tracer \[18F\]-VM4-037 in cancer patients in two dose-steps: * Step 1 (3-6 patients): a single dose of maximum 8 mCi (296 MBq) dose of \[18F\]VM4-037 via a bolus IV injection. * Step 2 (3-6 patients): a single dose of maximum 12 mCi (444 MBq) dose of \[18F\]VM4-037 via a bolus IV injection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [18F]VM4-037 | Bolus IV injection of \[18F\]VM4-037 |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2009-07-08
- Last updated
- 2013-01-25
Source: ClinicalTrials.gov record NCT00935142. Inclusion in this directory is not an endorsement.